ARVO SIG: Outcome measures for very low vision - HOVER 2.0

Register here: https://www.arvo.org/meetings-events/special-interest-group

Organizers

Lauren Ayton, University of Melbourne, Australia

Ben Thompson, University of Waterloo, Canada

Moderator

Ruth Hamilton, University of Glasgow, Scotland

In 2020, a guideline document on the measurement and reporting of very low vision clinical trial outcomes was published in TVST - named the HOVER document. In the subsequent years, the fields of gene therapy, stem cells and other low vision therapies have grown exponentially. This has been accompanied by related growth in the field of outcome measure research. We now wish to update these guidelines in the new HOVER 2.0 document.  This SIG will feature experts in various fields of low vision and outcome measure research, and discussion on the current and emerging trial design. This is your chance to provide your feedback on the content to be included in the HOVER 2.0 document as part of the working group process.

Panelists

Michael Bach, University Medical Center Freiburg, Germany

Jasleen Jolly, University of Melbourne, Australia

Adam Dubis, University of Utah, USA

Avril Daly, Retina International, Ireland